Purchase Order N0018315P1451
Award Date 4/29/15
Potential Completion Date 9/30/15
Potential Value $135K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46250, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $400,865.87 firm fixed price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, which does not have a set-aside designation, is for cost per test services. Roche Diagnostics has a history of providing critical care analyzers, reagents, test kits, and other laboratory equipment and supplies to...
- This is a $787,038.78 firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, which has no set-aside designation, provides for the delivery of Roche's medical diagnostic technologies, including laboratory equipment, testing systems, reagents, and clinical testing services, to support...
- This is a $92,104.71 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the renewal of a lab supply test requirement, with a period of performance through May 2020. Roche Diagnostics has been awarded multiple VA, Department of Defense, and other federal agency contracts to...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $947,520.62, was awarded by the Medical Command within the U.S. Department of Defense on October 1, 2020 for a period ending on September 30, 2021. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation....
- The U.S. Navy's Bureau of Medicine and Surgery awarded a $1.0 million firm fixed-price delivery order to Roche Diagnostics Corporation on September 29, 2023, with an ultimate completion date of September 30, 2024. This child delivery order, which carries no set-aside designation, reflects open competition and is performed at Roche's facility in Castleton, Indiana. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, specializes in in vitro diagnostics,...
- The U.S. government awarded a $10,813.50 Firm Fixed Price Purchase Order contract to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, with an ultimate completion date of September 30, 2007, does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated equipment, supplies, and services to various federal...
- Roche Diagnostics Corporation was awarded a federal contract on August 14, 2025, by the Defense Health Agency for COBAS Assembly supplies and services. This is a call order under a Blanket Purchase Agreement with a firm fixed-price structure and a ceiling value of $16,080.07. The work will be performed in Castleton, Indiana, with an ultimate completion date of September 30, 2025. This contract award carries no set-aside designation, indicating open competition in the federal marketplace. The...
- This firm-fixed-price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $175,000.00, has a completion date of September 5, 2023 and does not have a set-aside designation. Roche Diagnostics provides critical care analyzers, reagents, test...
- The Defense Health Agency awarded a delivery order valued at $482,006 to Roche Diagnostics Corporation for chemistry and immunoassay laboratory testing services on a cost-per-reportable-result basis. This non-set-aside contract, effective May 1, 2022, through April 1, 2023, will be performed at Roche's facility in Castleton, Indiana. The award utilizes firm fixed-price pricing under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration schedule, enabling the federal...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic equipment and reagents, has been awarded a delivery order valued at $722,715.31 by the Defense Health Agency for an Automated Core Lab. The order is firm fixed price with no set-aside designation and is scheduled for completion by September 30, 2025. The work will be performed in Castleton, Indiana, and represents a child contract—indicating it derives from a larger contract vehicle, likely one of Roche's...